Disclosure of material transactions with related parties in accordance with section 111c German Stock Corporation Act (AktG) Berlin, July 1, 2021 – As announced via the publication of an inside information pursuant to Art. 17 Market Abuse Regulation (MAR) on June 11, 2021 (“ad hoc announcement”), Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) has […]